Articles by Peter Whoriskey
We found 1 results.
As Drug Industry’s Influence over Research Grows, So Does the Potential for Bias
Peter Whoriskey – The Washington Post,
3 Dec 2012
For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup. The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best. A Food and Drug Administration scientist estimated, four years later, that the drug had been associated with 83,000 heart attacks and deaths.
→ read full article